mProbe Inc.

At mProbe we are transforming the fields of precision health and precision medicine with molecular diagnostic tools and analysis to improve disease risk screening and intervention effectiveness when compared to the current standards of care. Clinical outcomes matter most, but biology changes first. We have harnessed the ability to measure changes at the systems biology level so that disease onset, progression and care efficacy can be determined long before other clinical indicators- like weight loss, blood pressure, even blood chemistry - change. Our molecular tests facilitate the choice of optimized interventions based upon patient's risk and matched to the individual's biology providing the highest likelihood of success. mProbe utilizes our proprietary technology combination of artificial intelligence and multi-omic diagnostics to predict, prevent and cure disease precisely. mProbe has developed four product lines encompassing Precision Cancer Care, Precision Maternal/Child Care, Precision Health and Wellness, and Healthcare Analytics. In Precision Cancer Care we help oncologists choose the most efficacious chemotherapies and targeted therapies based on the individual's tumor biology. In Precision Maternal/Child Care, we measure healthy pregnancy progression and predict preterm birth and preeclampsia allowing families and their physicians to take preventive steps. We also provide precision diagnostics for diseases such as Kawasaki Diseases, etc. In Precision Health and Wellness, we predict chronic diseases and their complications with absolute probabilities enabling physicians and patients to take the necessary preventive steps. In Healthcare Analytics, through HBI Solutions'​ state of art machine learning and artificial intelligence, we offer breakthrough predictive risk technologies, cost reduction and quality measurement solutions to hospitals, pharmaceutical companies, regional health systems, and insurance companies